0001438133-24-000140.txt : 20240528
0001438133-24-000140.hdr.sgml : 20240528
20240528184426
ACCESSION NUMBER: 0001438133-24-000140
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240523
FILED AS OF DATE: 20240528
DATE AS OF CHANGE: 20240528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Novara Mark David
CENTRAL INDEX KEY: 0002000342
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36189
FILM NUMBER: 24993537
MAIL ADDRESS:
STREET 1: C/O TANDEM DIABETES CARE, INC.
STREET 2: 12400 HIGH BLUFF DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC
CENTRAL INDEX KEY: 0001438133
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 204327508
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
CITY: San Diego
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-366-6900
MAIL ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
CITY: San Diego
STATE: CA
ZIP: 92130
4
1
wk-form4_1716936259.xml
FORM 4
X0508
4
2024-05-23
0
0001438133
TANDEM DIABETES CARE INC
TNDM
0002000342
Novara Mark David
12400 HIGH BLUFF DRIVE
SAN DIEGO
CA
92130
0
1
0
0
EVP & CHIEF COMMERCIAL OFFICER
0
Restricted Stock Unit
2024-05-23
4
A
0
913
0
A
Common Stock
913
913
D
Performance Stock Unit
2024-05-23
4
A
0
913
0
A
Common Stock
913
913
D
Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).
Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2026 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSUs will vest.
/s/ Rachel Malina, Attorney-in-Fact for Mark D. Novara
2024-05-28